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Can screening and brief intervention lead to
population-level reductions in alcohol-related
harm?
Nick Heather*
Abstract
A distinction is made between the clinical and public health justifications for screening and brief intervention (SBI)
against hazardous and harmful alcohol consumption. Early claims for a public health benefit of SBI derived from
research on general medical practitioners’ (GPs’) advice on smoking cessation, but these claims have not been
realized, mainly because GPs have not incorporated SBI into their routine practice. A recent modeling exercise
estimated that, if all GPs in England screened every patient at their next consultation, 96% of the general
population would be screened over 10 years, with 70-79% of excessive drinkers receiving brief interventions (BI);
assuming a 10% success rate, this would probably amount to a population-level effect of SBI. Thus, a public health
benefit for SBI presupposes widespread screening; but recent government policy in England favors targeted versus
universal screening, and in Scotland screening is based on new registrations and clinical presentation. A recent
proposal for a national screening program was rejected by the UK National Health Service’s National Screening
Committee because 1) there was no good evidence that SBI led to reductions in mortality or morbidity, and 2) a
safe, simple, precise, and validated screening test was not available. Even in countries like Sweden and Finland,
where expensive national programs to disseminate SBI have been implemented, only a minority of the population
has been asked about drinking during health-care visits, and a minority of excessive drinkers has been advised to
cut down. Although there has been research on the relationship between treatment for alcohol problems and
population-level effects, there has been no such research for SBI, nor have there been experimental investigations
of its relationship with population-level measures of alcohol-related harm. These are strongly recommended. In this
article, conditions that would allow a population-level effect of SBI to occur are reviewed, including their political
acceptability. It is tentatively concluded that widespread dissemination of SBI, without the implementation of
alcohol control measures, might have indirect influences on levels of consumption and harm but would be unlikely
on its own to result in public health benefits. However, if and when alcohol control measures were introduced, SBI
would still have an important role in the battle against alcohol-related harm.
Introduction
The term “brief intervention” has been applied both to
shorter forms of treatment delivered in specialist alcohol
or addiction services and to interventions offered by
generalist professionals to individuals who are not seek-
ing help for an alcohol problem but whose alcohol con-
sumption is of concern. It has been argued that these
two uses of the term should be clearly distinguished
[1,2], and it is the second that is the focus of this article.
In this sense, it is better to use the term “opportunistic
brief intervention,” with the implication that the oppor-
tunity is taken of the drinker’s presence in a setting not
directly connected with help for alcohol problems to
offer advice and assistance to cut down consumption or
abstain. For convenience, however, this form of activity
will be called simply brief intervention (BI) here.
Brief intervention is directed at two separate targets:
hazardous drinkers, whose level or pattern of drinking
increases the risk of alcohol-related harm, and harmful
drinkers, who have already incurred some degree of
harm but who show no or only low levels of alcohol
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dependence [3]. Since, by definition, these individuals
are not seeking help to resolve an alcohol problem, it is
necessary to screen for level of consumption and/or the
presence of alcohol-related problems or employ some
other form of identification before BI can be offered.
The more specific aims of screening and brief interven-
tion (SBI) will be discussed below.
There is no single form of BI; rather, the term applies
to a family of interventions that differ in length, content,
and in a number of other ways [4]. Recently, however,
two distinct forms of BI have emerged: brief structured
advice and brief motivational interviewing. Brief struc-
tured advice is typically employed in time-limited situa-
tions, such as general medical practice, with immediate
intervention following screening. The intervention typic-
ally lasts between five and 10 minutes and usually con-
sists of a standard package involving information on
drinking risk levels, the status of the patient’s own drink-
ing in relation to those levels, encouragement to cut
down and set a date for doing so, and a few simple hints
on how cutting down might best be achieved, often ac-
companied by self-help material. Brief motivational
interviewing is a more flexible and client-centred ap-
proach that explicitly avoids giving advice unless it is
requested. It usually lasts between 20–40 minutes in a
single session and often includes follow-up sessions.
Based on the principles and techniques of motivational
interviewing [5], it was originally described in the early
1990s [6] and has been applied in settings and situations
where there is more time for intervention and where
staff trained in the approach are available.
Evidence for the effectiveness of SBI is good for pri-
mary health care [7], mixed for emergency services and
general hospitals wards [8,9], and virtually nonexistent
for other medical and nonmedical settings [10]. For pur-
poses of this discussion, however, and based on the as-
sumption that evidence for effectiveness in primary
health care can represent effectiveness among hazardous
and harmful drinkers in general, BI will be regarded as
effective with a number-needed-to-treat (NNT) of 10
[11]. It is also arguable that a public health benefit of
SBI, if it is possible, would come about mainly through
implementation in primary health care, because that
would impact upon the majority of individuals in the
population.
Aims
The aims of this article are as follows:
1) to trace the history of claims for the public health
benefits of SBI for hazardous and harmful alcohol
consumption (hereafter called excessive drinking).
2) to consider the conditions under which a
population-level benefit of SBI could arise.
3) to examine evidence on recent attempts to achieve
widespread implementation of SBI, the consequences
of those attempts, and the difficulties they have
encountered.
4) to contribute to the fourth objective of the
International Network on Brief Interventions for
Alcohol & Other Drugs (INEBRIA); that is,”To
promote the integration of the study of brief
interventions with the wider context of measures to
prevent and reduce alcohol-related harm.”
5) specifically, to consider the relationship between SBI
and alcohol control measures.
6) overall, to ask whether implementation of SBI can
lead to population-level reductions in alcohol-related
harm, to consider how this question could be
answered, and to offer a tentative answer to it.
Before proceeding, two general points should be made.
First, classic definitions of public health (e.g., "the sci-
ence and art of preventing disease, prolonging life, and
promoting health through the organized efforts of soci-
ety" [12]) can encompass a variety of activities and out-
comes. For the purposes of this article, the term “public
health benefit” refers to the favorable effects of policies
and interventions that are detectable in population-level
measures of, in this case, alcohol-related harm. Second,
although there is a great deal of high-quality information
from the US, Canada, and other parts of the world that
is relevant to the aims of this article, we will be mainly
concerned here with what the author knows best—evi-
dence and policies from European countries and, in par-
ticular, from the UK.
Clinical versus public health justifications for alcohol SBI
There are two ways of justifying the range of activities
that come under the heading of alcohol SBI. The clinical
justification is concerned with the interests of the indi-
vidual patient or client who receives the BI. The clinical
benefits are in terms of early intervention before harm
or, in the case of existing harmful drinking, more severe
harm has occurred and secondary prevention before
more intensive intervention may be required. Brief inter-
vention can also reduce the current level of alcohol-
related harm an individual may be experiencing. An
NNT of 10 compares very favorably with general practi-
tioner’s advice to quit smoking [13]. Even if the patient
does not respond at first, the intervention may start a
process described by movement along the stages of
change in the Transtheoretical Model [14]. This kind of
justification is of greatest appeal to clinicians, therapists,
and counselors concerned with the health and welfare of
the patients or clients they encounter in their practices.
The public health justification is not concerned with
the interests of individuals but with those of societies
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and, more specifically, with reducing the aggregate of
alcohol-related harm in the population at large. This is
achieved by reducing levels of alcohol-related problems
per se and also by decreasing levels of alcohol consump-
tion in the population linked to a wide range of physical
and mental ill-health [15]. It is reckoned that the wide-
spread delivery of SBI among excessive drinkers would
be a comparatively cost-effective way of reaching these
goals [16]. Although clinicians may recognize these
wider benefits of delivering SBI, they are mainly of inter-
est to public health specialists and policy makers.
An objection at this point might be that the distinction
above is artificial because, if enough individuals respond
positively to SBI, this would amount to an aggregate
public health benefit. This is true in a trivial sense. How-
ever, the premise here is that a form of intervention ap-
plied to individuals can only be described as having a
public health benefit if its effects are clearly detectable
in population-level measures of harm—in this case, for
example, in rates of alcohol-attributable mortality or
morbidity, rates of drunkenness or drunk-driving
offenses, or measures of alcohol consumption from ran-
dom surveys of the population or relevant community
samples.
If the distinction is accepted, an important point to
note is that the clinical justification is independent of
the public health justification. In other words, if it
were shown that widespread SBI had no detectable
public health effect at the population level, this would
in no way undermine the clinical justification for
offering SBI to individual patients or clients with the
aim of improving their health, welfare, and quality of
life.
Early claims for the public health potential of SBI
The trial of physician advice to quit smoking by Michael
Russell and colleagues reported in the British Medical
Journal in 1979 [17] is rightly regarded as a landmark
study of BI for substance use disorders and for the new
public health more generally. It was one of the main
influences on the development and trial in Scotland in
the early 1980s of the first alcohol BI pack for use in pri-
mary health care (the DRAMS pack [18]). (The
European origins of alcohol BI have been recently
described by Heather [19].) Russell and colleagues ran-
domly allocated 2138 smokers attending one of 28 gen-
eral practice surgeries in London to one of four
conditions: nonassessment controls; questionnaire-only
controls; advised by the general practitioner (GP) to stop
smoking; and advice, receipt of a leaflet, and warning of
follow-up. The quit rates one year after intervention for
these four groups were, respectively: 0.3%, 1.6%, 3.3%,
5.1%. The authors summarized the implications of their
findings as follows: “The results suggest that any GP
who adopts this simple routine [i.e., the fourth group]
could expect about 25 long-term successes yearly. If all
GPs in the UK participated, the yield would exceed half
a million ex-smokers a year. This target could not be
matched by increasing the present 50 or so special with-
drawal clinics to 10,000” (p.231).
This is probably the earliest statement of the public
health potential of SBI for reducing the harm from any
kind of unhealthy behavior. However, it is clear that, had
the authors’ expectations been realized, the smoking
habit in the UK would have been entirely eliminated
some years ago! (It would have resulted in 16 million ex-
smokers in the 32 years since the BMJ article; the
current prevalence of smoking in the UK is approxi-
mately 10 million.) Reasons why this has not happened
are not hard to find. First, there are the well-known dif-
ficulties in extrapolating the results of randomized con-
trolled trials to the real world of everyday practice.
Second, although smoking prevalence has declined in
many industrialized countries, experience has revealed a
recalcitrant rump of smokers who are harder to shift
from their habit [20]. Third, and most obviously, not all
GPs in the UK have adopted the “simple routine” in
question, or anything like it.
For the purposes of this article, a UK smoking re-
search expert, Dr. Martin Jarvis, was asked for his as-
sessment of the contribution BI has made to
reductions in smoking prevalence over the last 20 to
30 years. He replied that the main driver of reduced
prevalence has been a change in the social climate
surrounding smoking; i.e., the “denormalization” of
smoking. This had mainly been brought about by
advertising bans and smoke-free legislation, but price
increases have also been important. Against this back-
ground, it is difficult to disentangle the effects of
GPs’ advice and treatment in general, but uptake of
BI by smokers is far lower than it should be, and GPs
and other health professionals do not offer BI as
often as they should. The extent to which these remarks
transfer to desired reductions in the prevalence of exces-
sive drinking will be returned to.
The first well-resourced trial of GP-delivered SBI, result-
ing in the first good evidence for its effectiveness in any
setting, was carried out by Paul Wallace and colleagues
using the Medical Research Council GP Research Net-
work [21]. They randomly allocated 909 heavy drinking
patients from 47 group practices throughout the UK to
one of two groups: 1) advice and information about redu-
cing consumption plus a leaflet and up to five additional
sessions at the discretion of the GP; or 2) a noninterven-
tion control. At one year follow-up, the proportion with
excessive consumption had dropped by 43.7% in the inter-
vention group compared with 25.5% in controls, a differ-
ence that was highly significant. In what was no doubt a
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reflection of the earlier summary of the Russell et al. study
[17], Wallace and colleagues concluded that, “If the results
of this study were applied to the UK, intervention by GPs
could each year reduce to moderate levels the alcohol
consumption of some 250,000 men and 67,500 women
who currently drink to excess. GPs and other members of
the primary health care team should therefore be encour-
aged to include counseling about alcohol consumption in
their preventive activities” (p.663).
Again, if this potential had been realized, it would have
resulted in 5.75 million heavy drinking men and 1.55
million heavy drinking women becoming low-risk drin-
kers since Wallace et al.’s 1988 publication. Needless to
say, this has not happened. The reasons are similar to
those applying to smoking cessation (see above) but
chiefly because most GPs in the UK have not incorpo-
rated alcohol SBI into their routine work.
Modeling SBI effects
A more recent and sophisticated attempt to predict the
effect that widespread implementation of alcohol SBI in
primary health care would have on rates of excessive
drinking in the UK was made by a group from the
School of Health and Related Research at the University
of Sheffield [22]. This work was commissioned by the
National Institute for Health and Clinical Excellence
(NICE) in conjunction with the development of public
health guidance to promote the prevention and early
identification of alcohol use disorders in adults and ado-
lescents [23,24].
The Sheffield model involved integrating routine regis-
tration and attendance data in general practices and
emergency departments, cost information, linking scores
on the Alcohol Use Disorders Identification Test
(AUDIT) [25] with baseline consumption levels, and
Table 1 Three intervention models from the Sheffield Alcohol Policy Model, version 2
Next GP Registration Next GP Consultation Next ED Consultation
Baseline Scenarios Practice nurse undertakes both
screening and, where appropriate, BI
Physician undertakes both screening and,
where indicated, BI as part of consultation
Prescreen applied depending on reason
for attendance or diagnosis, screening
prior to discharge, BI offered as a
separate appointment on day after
screening
▸ Screening using full AUDIT followed
by 25-minute intervention
▸ Screening using full AUDIT followed by
25-minute intervention
▸ Assume 30% take-up of BI, prescreen
similar to PAT, screening with FAST,
followed by 50-minute intervention
▸ Screening using AUDIT-C followed by
5-minute intervention (similar to DES
configuration)
▸ Screening using AUDIT-C followed by
5-minute intervention (similar to DES
configuration)
▸ Screening using FAST followed by 5-
minute intervention
▸ Screening using FAST followed by
5-minute intervention
Results In all three cases, estimated costs of
delivering BI outweighed by financial
savings due to subsequent reduced
burden of illness
For 25-minute BI, estimated costs outweigh
health-care costs avoided, with net cost
overall and ICER of £5,900 per QALY
gained (i.e., cost-effective)
ICER estimated at £9,700 per QALY
(i.e., cost-effective)
QALY gains and, therefore, baseline
interventions estimated to be better
than “doing nothing”
For 5-minute BI, intervention costs lower
and ICER improved, i.e., cost-savings
Despite 10-year program involving
screening over three-fourths of adult
population, only 18% of hazardous/
harmful drinkers estimated to receive
BI due to low take-up rate of 30%
Screening on next registration
estimated to apply to 39% of
population of England over 10-year
period, with one-third of hazardous
and harmful drinkers being screened,
detected, and given BI
Different from next GP registration because
▸ GP staff costs higher than those of
practice nurse
▸ Men consult less frequently than women
▸ Patients consult GP much more frequently
than they change GP
Thus, 96% of population screened over 10
years (the majority in the first year) with
70-79% hazardous/harmful drinkers
receiving BI
Estimated gain is over 100,000 QALYs over
10-year screening program
GP=general practice; ED = emergency department; BI = brief intervention; AUDIT =Alcohol Use Disorders Identification Test (AUDIT-C = three AUDIT consumption
questions); DES = direct enhanced service; PAT = Paddington Alcohol Test; FAST = Fast Alcohol Screening Test; ICER = incremental cost-effectiveness ratio;
QALY = quality-adjusted life year.
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published research evidence on the effectiveness of BIs,
principally the Cochrane meta-analysis by Kaner and
colleagues [7]. Estimates were made of the effects of a
set of possible policies implemented over an assumed
10-year national screening program in England by quan-
tifying the costs of implementation, the effects on 47
health conditions, and savings in health care costs.
Crime and workplace harms were excluded. This project
was primarily an exercise in economic modeling, and, al-
though cost-effectiveness data are of interest, we will be
mainly concerned here with the modelling of SBI imple-
mentation and its effects.
All screening was considered to be opportunistic, and
an arrival profile was estimated for the proportion of
each population subgroup that would attend in the first
year of the screening program; repeat screening at sub-
sequent attendances was assumed not to occur. Screen-
ing was assumed to be carried out using the full AUDIT
[25], the AUDIT-C (the three AUDIT consumption
questions) [26], or the Fast Alcohol Screening Test
(FAST) [27]. Cost-effectiveness ratios were estimated in
terms of health care costs per quality-adjusted life year
(QALY) gained, similar to a standard NICE technology
appraisal. Three general scenarios for SBI were exam-
ined: 1) at the next GP registration (i.e., when patients
change their GP); 2) at the next GP consultation; and 3)
at the next consultation in an emergency care setting.
Table 1 shows the main assumptions underlying each
scenario and their estimated effects over a 10-year
period.
Despite the cost-effectiveness of the emergency de-
partment scenario shown in Table 1—i.e., an incremental
cost-effectiveness ratio (ICER) of £9,700 per QALY—
being within standard NICE guidelines, the results for
this scenario are disappointing. While it was calculated
that 78% of the adult population would be screened in
this setting within 10 years, because of an estimated
take-up rate of just 30%, only 18% of excessive drinkers
would receive a BI. It is also relevant that evidence for
effectiveness of SBI in emergency care is inconclusive
[8]. Consequently, we focus here on the two GP-based
scenarios that were applied to the English population
aged ≥11.
There is evidence of the cost-effectiveness of SBI in both
GP scenarios in Table 1, with cost-offsets for the next GP
registration (i.e., estimated costs of delivering SBI were
outweighed by financial savings due to a subsequently
reduced burden of illness). The main comparison of inter-
est between these two scenarios for present purposes,
however, concerns the proportions of the general popula-
tion who would be screened and the proportion of exces-
sive drinkers in the population who would receive a BI.
Thus, screening at the next registration was estimated to
apply to 39% of population of England over a 10-year
period, with one-third of hazardous and harmful drinkers
being screened, detected, and given a BI. In the Next GP
consultation scenario, it was estimated that 96% of the
population would be screened over 10 years (the majority
in the first year), with 70-79% of hazardous/harmful drin-
kers receiving a BI.
In considering the findings of this economic
model, the many assumptions underlying it should
be borne in mind. For example, it was assumed that
all patients visiting their GP over a 10-year period
would be screened (but only once), all those screen-
ing positive would be offered a BI (but only once),
and all those offered a BI would accept it. The
assumptions that screening and the offer of BI would
occur only once in routine practice might be consid-
ered unrealistic. The further assumption that mean
alcohol consumption in the years following a BI can
be adjusted by using a “rebound to baseline” of
seven years, based on data reported in the US by
Fleming and colleagues [28], may be regarded as es-
pecially questionable in the UK context. The impacts
on morbidity and mortality were estimated by a
“consumption-to-harms” model, but the relationship
between consumption and screening score was based
on limited survey data. While the effects of BI of
different lengths were estimated from the Kaner
et al. meta-analysis [7], the effects of possible
booster sessions were excluded, and there were
assumed to be no variations in BI effectiveness when
delivered by different staff members. If incorrect to
various degrees, some of these assumptions would
result in overestimation of the cost-effectiveness of
SBI and some in underestimation.
Despite the qualifications and misgivings that arise
from the Sheffield economic model, its findings are
useful for suggesting two broad conclusions. First,
because of its limited reach, SBI confined to new
patient GP registrations is likely to result in only a
modest reduction in the prevalence of excessive drin-
kers in the population, and, assuming a BI success
rate of 10% [3], one that may not be detectable on
population-level measures. On the other hand,
because of its much wider penetration, opportunistic
screening at each patient appointment would be likely
to have a detectable impact on the prevalence of
hazardous and harmful drinkers in the population
and would be a cost-effective means of achieving this
impact.
Public health benefit presupposes widespread screening
Targeted versus universal screening
If a population-level benefit of SBI is possible, the find-
ings of the Sheffield model suggest that it must be based
on widespread screening, including nearly the whole
Heather Addiction Science & Clinical Practice 2012, 7:15 Page 5 of 14
http://www.ascpjournal.org/content/7/1/15
population and, thus, the majority of excessive drinkers.
However, recent English government policy favors tar-
geted over universal screening in general practice and
other medical settings. In a Direct Enhanced Service
[DES] commissioned through the Primary Care GMS
Contract, GPs are directed to offer an alcohol screen to
all new registrants aged 16 and older [29]. (There are a
few local variations to this; e.g., NHS South of Tyne &
Wear has introduced a Local Enhanced Service that
gives payment for universal screening but also gives
guidance on targeted groups.) In this way, the DES for
alcohol SBI compares unfavorably with the set-up for
smoking cessation interventions that are included as part
of the Quality and Outcomes Framework (QOF), in
which GPs are rewarded for intervening among all smo-
kers in the practice.
In Scotland, where a more severe national alcohol
problem is reflected in more government action com-
pared with the other UK countries, there has been a
health service target of delivering 149,449 BIs during the
period 2008/09–2010/11 [30]. This target has been met
(174,205 interventions delivered) and has been extended
for another year. This is commendable, but the target is
based on clinical presentation and new registrations, not
on universal screening.
Guidance issued by NICE recommends that NHS pro-
fessionals should carry out universal screening if pos-
sible; but if not, they should conduct targeted screening
in clinics and presentations where heavy drinking
patients are most likely to be found [23]. The recourse
to targeted screening by NICE and in national policies is
partly a reflection of evidence that health care profes-
sionals much prefer targeted screening and often find
universal screening unacceptable [31]. It must also be
said that there is considerable resistance to universal
screening from some sections of the medical profession,
presumably due to the increased workload it implies.
This tendency was encouraged by the 2003 publication
in the BMJ of an article by Beich and colleagues from
Denmark [32] alleging that screening in general practice
“does not seem to be an effective precursor to brief
interventions targeting excessive alcohol use” (p. 536).
This conclusion is debatable, but the main point is that
the public health potential of SBI is unlikely to be rea-
lized without the widespread deployment of universal
screening.
A nationwide screening program for excessive drinking?
The concept of universal screening, wherein individual
medical practices and practitioners are reimbursed or
Table 2 Criteria used by the UK National Screening Committee for the appraisal of a new formal screening program
and verdict applied to alcohol misuse
Criterion Verdict
1. The condition should be an important health problem √
2. The epidemiology and natural history of the condition, including development from latent to declared disease, should be adequately
understood, and there should be a detectable risk factor, disease marker, latent period, or early symptomatic stage
?
3. If the carriers of a mutation are identified as a result of screening, the natural history of people with this status should be understood,
including the psychological implications
N/A
4. All the cost-effective primary prevention interventions should have been implemented as far as practicable ?
5. There should be a simple, safe, precise, and validated screening test X
6. The distribution of the test values in the target population should be known and a suitable cut-off level defined and agreed X
7. The test should be acceptable to the population ?
8. There should be an agreed policy on the further diagnostic investigation of individuals with a positive test result and on the choices
available to those individuals
√
9. If the test is for mutations, the criteria used to select the subset of mutations to be covered by screening, if all possible mutations are not
being tested, should be clearly set out
N/A
10. There should be an effective treatment or intervention for patients identified through early detection, with evidence of early treatment
leading to better outcomes than late treatment
√
11. There should be agreed evidence-based policies covering which individuals should be offered treatment and the appropriate treatment
to be offered
√
12. Clinical management of the condition prior to participation in a screening program and patient outcomes should be optimized in all
health care providers
?
13. There should be evidence from high-quality randomized controlled trials that the screening program is effective at reducing mortality or
morbidity
X
√= criterion met.
X = criterion failed.
? = verdict uncertain.
N/A = criterion not applicable.
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otherwise take responsibility for delivering SBI, is differ-
ent from that of formal nationwide screening program.
In the UK, a national screening program represents a
systematic attempt by central government, carried out
mainly via general medical practice, to screen the entire
population, or the relevant parts of it, for early signs of
specific conditions. Proposals for such a program are
assessed by the UK National Screening Committee
(NSC) using a standard set of 13 criteria that any condi-
tion must meet to be accepted for mass screening. Con-
ditions that have passed this test and are now targets for
mass screening include breast and/or cervical cancer
among women, congenital heart disease among the new-
born, and bowel cancer among all adults. An appraisal
of the suitability of “alcohol misuse” against these cri-
teria was recently carried out by the organization Solu-
tions for Health on behalf of the Department of Health
[33]. Alcohol misuse was not recommended for a formal
NSC screening program, and it is relevant here to ask
why.
The criteria used by the NSC are shown in Table 2
together with a “verdict” for each from the appraisal.
The appraisal is a curious document in some ways
because, for the majority of criteria, it is not expli-
citly stated whether or not the criterion in question
has been met or has failed. While some of the cri-
teria appear from the text to be met by alcohol mis-
use and others appear questionable, yet others that
seem unlikely to be met are not given as a reason
for rejection; e.g., “All the cost-effective primary pre-
vention interventions should have been implemented
as far as practicable” [4].
The two criteria explicitly identified as grounds for
rejection are as follows:
 Number 5: There should be a simple, safe, precise
and validated screening test. It is concluded that,
while the AUDIT [25] is the most validated
screening tool, and there is evidence that it is
effective in identifying Caucasian men who misuse
alcohol, there is no single questionnaire or test that
has been validated for all subgroups of the
population. Cut-off points have yet to be defined for
some subgroups, such as young people, women,
cultural minorities, and those over 65. A
consequence of using self-reported behavior and
behavioral change is that there is no independent
measure, such as a biomarker, that can provide a
single gold standard against which the performance
of screening questionnaires can be measured. This is
a prerequisite of a formal screening program set out
in the criteria laid down by the NSC. (This basis for
rejection seems also to apply to criterion 6 in
Table 2.)
 Number 13. There should be evidence from high-
quality randomized controlled trials that the
screening program is effective in reducing mortality
and morbidity. The appraisal concludes that there is
currently limited evidence and no randomized
controlled trials showing that the short-/medium-
term reductions in alcohol intake shown in
Caucasian men have an impact on morbidity and
mortality rates and social harm. A demonstrable
reduction in morbidity and/or mortality rates as a
result of screening is a prerequisite for a formal
screening program.
Any disappointment that might be felt at this deci-
sion is perhaps tempered by the fact that other ser-
ious health conditions, such as depression and
Alzheimer's disease, have also failed to meet NSC cri-
teria for nationwide screening. The direct implications
for the alcohol field are that, if it is desired to aim
for population-level decreases in alcohol-related harm
by means of screening the whole population, screen-
ing tests must be developed that meet NSC require-
ments, and RCTs with sufficient follow-up to
demonstrate positive effects of SBI on rates of mor-
bidity and mortality must be published.
Screening results from the Swedish Risk Drinking Project
While governments around the world have, so far,
been reluctant to attempt widespread implementa-
tion of SBI throughout national health systems, there
are some exceptions. One of these is the Risk Drink-
ing Project carried out in Sweden from 2004 to
2010. This was probably the largest coordinated
attempt so far to implement SBI in a single country
[34]. The project was based on a government initia-
tive to give alcohol issues a more prominent place in
routine primary, maternity, and occupational health
care, involving both physicians and nurses. It had
total funding of approximately 25 million Euros.
Using occupational health care alone as an illustra-
tion, 22 courses were carried out teaching the Risk
Drinking Model: i.e., screening with AUDIT and a
biological marker (carbohydrate deficient transferrin
[CDT]), followed by feedback and BI. In total, 530
workers within occupational health care participated
in the training. In addition, more than 900 workers
participated in half- and whole-day information
seminars and network meetings for knowledge and
experience exchange within occupational health care.
Fourteen national conferences were held across the
country in cooperation with the Confederation of
Swedish Enterprise, the Swedish Association of Local
Authorities and Regions, the employers’ association
known as Alecta, and the insurance firm, AFA. In
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addition, 160 local and regional workplace seminars
were held in cooperation with occupational health
care units and workplaces nationwide, with approxi-
mately 6000 participants. This gives some idea of the
ambition and reach of the project.
It should be noted here that occupational health
care in Sweden, as well as in Finland and some other
European countries, is quite different from the
employee assistance programs found in the US. The
Swedish working population mainly uses occupational
health care as a first point of contact for the treat-
ment of acute and chronic illnesses. Primary health
care outside the employment setting is mainly used
by children, the elderly, and the unemployed. In this
way, occupational health care in Sweden is an integral
part of the primary care system.
The Risk Drinking Project was carefully evaluated,
and findings are currently being published [35]. In
one evaluation study [36], a telephone-administered
questionnaire was completed between 2006 and 2009
by a representative sample of approximately 72,000
adults from the Swedish-speaking general population.
An “alcohol enquiry” was defined as having been
asked about one’s drinking by a physician in any
health care visit in the last 12 months. Among “haz-
ardous drinkers” (i.e., all those drinking over recom-
mended limits), 17% of men and 13% of women who
had visited a physician in the last year recalled having
received an alcohol enquiry, while among “sensible
drinkers” (i.e., all those drinking at or below recom-
mended limits), 15% of men and 10% of women did
so. Overall, 14% of the sample recalled having
received an alcohol enquiry. Although it is encour-
aging that more hazardous drinkers remembered an
alcohol enquiry than sensible drinkers, the fact is
that, despite the massive effort to persuade medical
practitioners to screen for alcohol consumption, only
14% of the people surveyed could recall being asked
about their drinking.
Public health benefit presupposes widespread
implementation of brief interventions
As well as screening, the possibility of a public health
benefit from SBI must presuppose the widespread deliv-
ery of BI. Recent research from Sweden and Finland,
probably the two countries in which SBI has been imple-
mented most widely, is relevant to the issue of the con-
sequences of widespread BI.
Brief intervention results from the Swedish Risk Drinking
Project
In another evaluation of the effects of the Risk Drinking
Project [37], a questionnaire was mailed to a randomly
selected representative sample of the Swedish population.
The questionnaire asked whether alcohol had been dis-
cussed at a health care visit during the past year and, if so,
what were the duration, contents, experience, and effects
of any conversation about drinking. Of the 66% of the
sample who had visited health-care services in the last
year, 20% reported having had one or more conversations
about alcohol during these visits; this figure was extrapo-
lated to 13% of the Swedish population aged 18–64 years.
The duration of conversations was generally brief, and the
contents, experiences, and effects varied according to the
type of drinker concerned. Reduced alcohol consumption
as a consequence of intervention was reported by 12%
and, interestingly, was more likely to be reported when
the conversation lasted for 1–10 minutes (versus one mi-
nute) and included advice on how to cut down. There are
encouraging aspects of these results, but, once more, the
basic finding is that, despite the enormous effort to imple-
ment BI in the Swedish health-care system, only 13% of
the population recalled having discussed drinking with a
health-care practitioner during the past year.
Brief interventions: the Finnish experience
In Finland, there has been a concerted attempt since the
early 1990s to increase health professionals’ SBI activity
and induce favorable attitudes toward it, accompanied
by extensive training and support from researchers. This
was supplemented by a government-funded project
starting in 2004 known as the National Brief Interven-
tion Project (VAMP) [38]. With funding of 2.5 million
Euros, about 2000 nurses and 1000 general medical
practitioners were trained and supported to carry out
SBI. The participating municipalities represented about
25% of the Finnish population, but there was also a con-
certed attempt to cover the whole country. There was
also a separate Occupational Health Care Project in
which an additional 2000 health professionals were
trained [38].
A study was mounted to examine how far these wide-
spread and persistent efforts to implement SBI had
resulted in the “institutionalization” of SBI activity
among Finnish physicians between 2002 to 2007 [39]. In
that time, the proportion carrying out SBI increased
from 59% to 79%, with regular activity increasing from
9% to 17% and occasional activity from 50% to 61%. Of
those who were conducting SBI in 2007, 52% reported
increased activity compared with five years earlier. The
authors concluded that, despite the continuing challenge
of training and motivating those with low SBI activity,
implementation among Finnish physicians was reason-
ably high with an increasing trend.
Another project aimed to evaluate how far this effort
had impacted the Finnish general public and how well it
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reflected public opinion [40]. Face-to-face interviews
were carried out in 2008 with a random sample of 2725
Finns aged 15–69 from the general population. The
great majority of the sample (over 90%) had positive atti-
tudes toward being asked about drinking, but, of those
who had been in contact with health care in the last
year, only one-third recalled being asked, and these were
predominantly young male heavy drinkers and those of
higher socioeconomic status. Of those who had been
asked, although 37% overall had been given advice about
drinking, 50% of heavy drinkers had received no advice.
In interpreting these findings, the self-report na-
ture of the data should be taken into account. It is
possible that respondents either forgot their physi-
cians asked them about alcohol or that respondents
did not wish to admit that they had discussed their
drinking with their physician due to the stigma asso-
ciated with alcohol problems. This would suggest
that the estimates provided are lower than the real
extent of penetration. Nevertheless, this does not
alter the conclusion that, despite the substantial ef-
fort to institutionalize SBI in the Finnish health care
system over the years, and despite positive public
opinion regarding alcohol SBI, the extent to which
people are being asked about their alcohol consump-
tion, and the extent to which heavy drinkers receive
advice about it, is still lower than would be required
to produce a population-level reduction of excessive
drinking or alcohol-related harm in Finland.
Research on the relationship between treatment for
alcohol problems and population-level harm
Even the most enthusiastic modeller would concede that
empirical research is a superior form of evidence. Unfor-
tunately there is a dearth of empirical evidence on the
relationship between SBI and population-level measures
of alcohol-related harm. There is, however, a small body
of research on the relationship between the provision of
formal treatment for alcohol problems and population-
or community-level harm, and this might be considered
relevant to present interests.
The first such study was carried out in Stockholm,
Sweden [41], where there had been an impressive
decline in inpatient care for liver cirrhosis and pan-
creatitis from around 1978 to 1984, combined with
similar decreases in rates of alcoholic psychosis, al-
cohol dependence, and alcohol intoxication requiring
treatment. Using time-series analysis, the author
concluded that most of this decrease could be
accounted for by a 20% fall in alcohol sales during
the period in question, but that a large increase in
the sale and use of disulfiram and calcium carbimide
could be implicated too.
A larger scale time-series analysis was carried out by
Holder and Parker [42] using data from the US state of
North Carolina between 1968 and 1987. Beginning with
established evidence that alcohol consumption is an im-
portant determinant of levels of liver cirrhosis mortality,
the authors enquired why this relationship had not been
apparent in some data from the USA and Canada and
hypothesized that an increase in treatment for alcohol
dependence had resulted in a disjuncture in the relation-
ship between consumption and cirrhosis mortality. This
hypothesis was confirmed by the analysis. The authors
interpreted their results as showing clearly that treat-
ment for alcohol dependence, provided in sufficient
quantity in a large geographical area, can result in sig-
nificant reductions in liver cirrhosis mortality.
This reduction mainly took the form of a short-term
lagged effect in which treatment appeared to delay death
among individuals with advanced liver disease. Thus, al-
though this is probably the strongest piece of evidence
in support of a public health effect of treatment, its rele-
vance to the population of those who typically receive
BIs, and who are unlikely to suffer from severe liver dis-
ease, must be doubted.
Although the studies above are valuable, this topic is
mainly associated with research by Robert Mann, Regi-
nald Smart, and their colleagues from the former Addic-
tion Research Foundation in Toronto, Canada. In their
first publication [43], the authors examined changes in
treatment for alcohol problems in the Canadian province
of Ontario and in per capita alcohol consumption and
rates of liver cirrhosis, the latter of which had substan-
tially decreased in the years immediately preceding the
research. They concluded that, with the exception of a
single area of the province, increases in treatment were
linearly related to decreases in hospital discharges for
cirrhosis. However, the method of analysis was consid-
ered inadequate for the purpose intended by Holder and
Parker [42].
In the latest publication on this topic [44], this re-
search group tested the hypothesis that rates of cirrhosis
mortality are positively associated with per capita alco-
hol consumption and negatively associated with rates of
membership in Alcoholics Anonymous, again using data
from Ontario from 1968 to 1989. Both arms of this hy-
pothesis were supported in the analysis. While rightly
warning that the limitations of the study restricted the
ability to infer a causal relationship, the authors claim
that their findings are consistent with previous research
indicating that AA membership can reduce cirrhosis
mortality.
Evidence on whether programs for high-risk drinkers,
including opportunistic BIs, can have an impact on
population or aggregate levels of alcohol problems was
reviewed and discussed by Smart and Mann in 2000
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[45], together with some useful commentaries on their
article. The authors concluded, “Programs for high-risk
drinkers can have beneficial aggregate-level effects and
are thus a valuable component of population-based
efforts to reduce alcohol problems” (p.37). A number of
commentaries, however, pointed to the complexity of
the relationship in the real world between programs at
the individual level, traditional preventive policies, and
aggregate measures of harm [46-48]. It should also be
noted that these claims for population-level effects con-
cern only alcohol problems per se, including 100%
alcohol-attributable disease, and not the wider range of
mortality and morbidity in which drinking is implicated.
The emphasis in this research on rates of liver cirrhosis
as a measure of aggregate alcohol-related harm and the
limited relevance of this measure to the effects of SBI
has already been noted.
Perhaps the most useful conclusion from this body of
research for present purposes is that there appears to be
no good reason why similar studies could not be carried
out on the effects of SBI. If a geographical area can be
identified in which the level of SBI activity over time can
be accurately recorded, and there exist reliable population
measures of alcohol-related harm, preferably beyond cir-
rhosis mortality rates, then it should be possible to exam-
ine the relationship between these two sets of variables
and see whether a prima facie case can be made for a pub-
lic health effect of SBI.
Experimental investigations of population-level effects of
SBI
The fundamental limitation of the evidence just sum-
marized is, of course, that it is correlational in nature;
thus, it is difficult to adduce causal relationships be-
tween variables. Unfortunately, there appear to be no
published experimental studies exploring the hypothesis
that widespread SBI can lead to population-level effects.
In this section, we will briefly consider the kinds of study
design that might be directed to this hypothesis.
Natural experiments
Researchers should be on the lookout for opportunities
to compare aggregate measures of alcohol-related harm
from geographical areas and communities in which SBI
has been intensively implemented over a protracted
period of time with other areas, similar as far as possible
on relevant demographic and other background vari-
ables, where it has not. This is the weakest form of
experimental evidence but better than nothing.
Quasi-experimental designs
This involves implementing SBI intensively in a selected
area or areas and not implementing it in other areas
matched as far as possible on relevant background
variables (e.g., sociodemographic composition, baseline
level and variability of alcohol consumption etc. [49]).
After a stipulated period, identical or at least comparable
aggregate measures of harm, including possibly findings
from before/after random surveys of the general popula-
tion, would be compared between experimental and
control areas. Interestingly, this kind of design was con-
sidered at some length by investigators as the basis for
Phase IV of the WHO Collaborative Project on the Iden-
tification and Management of Alcohol-related Problems
in Primary Health Care [50] before it was concluded that
it would be too difficult for a multi-country project of
this kind and the action research framework that was
eventually used was agreed upon [51]. Nevertheless, a
collection of quasi-experiments, designed to discover
whether a population-level benefit of widespread SBI
could be detected, was thought to be the logical conclu-
sion to a 20-year project in which SBI had been devel-
oped and tested.
There are, of course, formidable difficulties with quasi-
experimental designs. These include the problem of
matching experimental and control areas on possible
confounding variables and of controlling the required
level of SBI activity (i.e., intensive over time in experi-
mental areas and absent over time in control areas).
Nevertheless, quasi-experimental designs have a respect-
able place in the history of alcohol-problems research
and have provided evidence for the effectiveness of
community-based prevention projects [52,53]. One study
of this type [54] included BI given by GPs as part of a
community-based prevention program under study, but
it was not possible to isolate the effects of SBI from
those of the other program components. However,
quasi-experimental designs can, in principle, be applied
to the question of public health benefits from SBI and
are needed to provide empirical evidence on the ques-
tion of whether such benefits are large enough to be
detected.
Cluster randomized controlled trials
This is the most rigorous type of design in this list and
again has a respectable place in research on community-
based prevention programs [55]. The unit of randomisa-
tion here would be communities in which SBI was or was
not intensively implemented. While individual patient data
would be of interest, the main outcome variables would
be aggregate data on alcohol-related harm from each
community. Projects of this kind to evaluate the
population-level effects of SBI are also needed.
Necessary conditions for a population-level effect of SBI
Before proceeding to the final section of this article, it
will be useful to summarize the conditions that it must
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be assumed are necessary for a population-level effect of
SBI to occur.
1) All or nearly all people in the population are
screened, and the great majority of excessive drinkers
in the population are identified and offered a BI.
2) BI reduces consumption to low-risk levels in some of
those who receive it (around 10% based on present
data).
3) Reductions in consumption resulting from BI are
relatively long-lasting.
4) There is a dose–response relationship between
alcohol consumption and harm such that reductions
in consumption among excessive drinkers lead to
reductions in harm.
With the exception of the second item, all these neces-
sary conditions are currently unlikely, either because they
are difficult to achieve or because there is no evidence to
support them. In the case of the first assumption, evidence
from Sweden and Finland suggests that, even after thor-
ough, persistent, and expensive national programs to im-
plement SBI, no more than a half of excessive drinkers
will receive advice about their drinking.
Even when that advice is received and results in behav-
iour change, there is little evidence that these changes
will be sustained over time. The only good evidence for
the durability of low-risk drinking following BI comes
from the work of Fleming and colleagues [56] who
reported continuing benefits of BI four years after inter-
vention. This study is relied on in nearly every discus-
sion of the long-term benefits of BI in the world
literature. In a 10–16 year follow-up of the sample
recruited in the well-known Malmö community health
screening project, Kristenson and colleagues [57]
reported that intervening had reduced mortality among
middle-aged men, but it is doubtful whether the original
intervention could meaningfully be described as brief. A
10-year follow-up in Australia [58] failed to find evi-
dence that, in the absence of booster sessions, BI could
sustain significant long-term reductions in drinking.
Thus, much better evidence is needed for the sustained
effects of BI before the third condition above can be
regarded as met.
In the case of the fourth condition, there is copious
evidence that increased consumption is associated with
higher rates of mortality, morbidity, and other types of
harm. However, this is different from the requirement
that reductions in consumption among those who have
been drinking heavily, sometimes for many years, are
associated with reductions in harm. As discussed earlier,
the NSC insisted that more evidence was needed that
SBI led to reductions in mortality and morbidity before
it could be considered for a mass screening program.
The political acceptability of widespread SBI
Another necessary condition for a population-level effect
might be that widespread implementation of SBI is
politically acceptable. Recently in England, the NHS
Future Forum, a body set up by the government to
provide advice on the future of health services, recom-
mended a transformation in the relationship between
NHS staff and patients in order to reduce the toll of ill-
health, and the cost to the NHS of rapidly rising num-
bers of people with ill-health linked to lifestyle [59].
Dubbed “make every contact count,” the proposal is for
all health-care professionals—not just physicians and
nurses, but surgeons, midwives, health visitors, phy-
siotherapists, pharmacists, dentists, etc.— to routinely
talk to patients about lifestyle, even when the presenting
problem has no obvious connection with it; and, when
required, offer motivationally-based advice on lifestyle
change [60]. The aspects of lifestyle to which this applies
are diet, smoking, alcohol intake, and exercise. These
ideas are very familiar, of course, to anyone interested in
promoting BI for unhealthy behaviors, and, in specific
regard to alcohol-related harm, seem to offer much
promise. The recommendations were accepted by the
Secretary of State for Health, Andrew Lansley, although
whether they will become official government policy has
yet to be seen.
The Future Forum report has been met with protests
from both sides of the political spectrum. Critics on the
right complain that the policy will intrude on patients’
freedom to choose how to live their lives and smacks of
“the nanny state,” while characterizing the advice to be
offered as “lecturing” and “preaching.” On the other hand,
critics on the left argue that the recommendations are part
of the government’s aim of shifting the focus of debate
about health issues away from structural approaches to
dealing with health inequalities in society to individual
responsibility for lifestyle change. The idea that health
inequalities can be addressed by personal advice on life-
style is seen as simplistic and ideologically driven.
Whatever the merits of these opposite reactions, the
point for present purposes is that the level of SBI imple-
mentation which, it has been argued in this article,
would be necessary for a population-level effect to
emerge—a scenario in which every time one made con-
tact with a health professional, for any reason, one
would be asked about one’s drinking and, in many cases,
be advised to cut down—might not be tolerated by the
general public, not to mention the health professionals
asked to deliver it, and might therefore be an electoral li-
ability to any political party supporting it.
SBI and alcohol control measures
We reviewed above the conditions that may be necessary
for a population-level effect of SBI to occur. But this
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assumes that SBI activity affects alcohol consumption
and harms in a straightforward fashion, without interac-
tions with other influences on drinking in society. In
reality, the factors that are causally related to alcohol
consumption make up a complex system of interacting
forces.
One especially important set of influences is the alco-
hol control measures in operation in a jurisdiction at
any one time. These measures refer mainly to laws and
policies on taxation and their effects on the affordability
of alcoholic products, the availability of alcohol, both in
terms of the density of alcohol outlets and trading hours,
and the marketing of alcoholic products, including
advertising and promotions of various kinds. There is
now a consensus among scientists in the alcohol field
that these are the strongest determinants of per capita
alcohol consumption [61]: under the whole population
theory of alcohol problems, the level of per capita con-
sumption determines the overall level of alcohol-related
harm in a society [62,63].Policies that increase price or
reduce availability and marketing are, therefore, the most
effective measures for preventing and reducing alcohol-
related harm [61]. But how does SBI relate to these
measures?
Widespread SBI without alcohol control measures
Despite strong evidence for their effectiveness, alcohol
control policies have seldom been implemented by
governments, probably because of fears that they
would be unpopular with the electorate. It has been
argued that, given the reluctance of governments to
enact these policies, the widespread implementation
of SBI might be the only alternative for making a
public health impact on alcohol-related harm [64].
However, there is also a suspicion, alluded to above,
that an appeal to SBI might be used by governments
to deflect attention from alcohol control measures
and other societal changes necessary to reduce alco-
hol problems.
Beyond a direct effect on alcohol consumption and
problems, however, widespread SBI might have indirect
effects at community or population levels. It could, for
example, encourage more health-care professionals to
become involved in advocacy for effective preventive
measures, including alcohol control measures [65], and
perhaps influence community or even national policy
agendas. Since a large proportion of the harm done by
alcohol is “third-party damage” [66] (i.e., harm to others
besides the drinker), widespread SBI could have benefits
for families, employers, and entire communities. Prob-
ably of most importance, it might raise public awareness
of alcohol-related harm and help foster the kind of
“denormalization” of excessive drinking that is thought
to have been crucial in reducing smoking prevalence in
industrialized countries over the past few decades [67].
Another intriguing possibility is that decreases in
alcohol consumption brought about in recipients of
successful SBI could lead to further reductions among
their family and friends by changing obligations and
expectations and by modelling, which could result in
a further ripple effect on drinking behavior through-
out a community. This was the “snowball” mechanism
proposed by Ledermann [68] to account for the fact
that a decrease in the population mean of alcohol
consumption did not affect the dispersion of the dis-
tribution and is a construct also central to Skog’s
analysis [69] of the collectivity of drinking cultures.
On an obviously speculative basis, it could be an
indirect mechanism for any population-level effects
widespread SBI might have.
Thus, there are reasons to believe that widespread SBI
without control measures could lead indirectly to
population-level reductions in alcohol-related harm, if
only by increasing the public acceptability of those con-
trol measures. However, the evidence reviewed above
suggests that SBI would need to be very widely dissemi-
nated indeed for this to happen, certainly above a level
of dissemination that has so far occurred anywhere in
the world.
Widespread SBI with alcohol control measures
Even if alcohol control measures were introduced by
government, SBI would still have an important role to
play in the battle against alcohol-related harm. This is
because the two policies would have reciprocal benefits
and synergistic effects.
First, it is reasonable to assume that changes in drink-
ing behavior brought about by SBI are harder to main-
tain in an environment that encourages heaving drinking
through the easy availability of cheap alcohol and
the seductive marketing of alcoholic products. Thus, the
introduction of control measures would be likely to
lower the relapse rate following successful SBI. Con-
versely, increases in price and restrictions on availability
could lead drinkers to try to cut down on their drinking,
and some, especially those with some degree of alcohol
dependence, might find this difficult without the help
and support offered by SBI. Moreover, what was said at
the beginning of this article should be reiterated: that is,
the clinical benefits of SBI—the lowering of risks of
harm among individual hazardous drinkers and the
reductions in actual harm among harmful drinkers—
exist independent of any population-level effects it might
or might not have. And, however successful control
measures might be in lowering per capita consumption
and population harm, there would still be many indivi-
duals who would benefit from SBI.
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Conclusions
The first conclusion from this discussion is that it is
impossible to be confident about an answer to the
question that forms the title of this article; namely,
can SBI lead to population-level reductions in
alcohol-related harm? This is because of a lack of
empirical evidence as to whether widespread SBI can
reduce alcohol-related harm as detectable on popula-
tion-level, or at least community-level, measures.
Even correlational studies, such as have been con-
ducted on the relationship between treatment
for alcohol problems and population-level harm, are
lacking in the SBI field. In the absence of this em-
pirical evidence, we have to rely on estimates from
modelling that suggest public health benefits would
only occur if SBI were disseminated widely through-
out a population. Even then, we need more assur-
ance from long-term prospective research that
reductions in consumption brought about by BI
would be sustained sufficiently to enable population-
level effects to occur.
There is no evidence at present that any national
health care system has reached the degree of penetration
of SBI necessary for population-level effects. This applies
even to countries like Sweden and Finland, where the
necessary conditions seem most propitious for this to
happen. National mass screening programs could pos-
sibly have the desired impact but, according to the opin-
ion of the NSC, there is a need for evidence that SBI
results in reductions to alcohol-related mortality and
morbidity and for the development of a simple, safe, pre-
cise, and validated screening test before standard criteria
for mounting such a program can be met. There must
also be a question whether the intensive dissemin-
ation of SBI that appears necessary would be politic-
ally acceptable both to health professionals and to
the general public.
Widespread dissemination of SBI without the imple-
mentation of alcohol control measures might have indir-
ect influences on alcohol consumption and harm but
would be unlikely on its own to result in public health
benefits. However, if and when alcohol control measures
are introduced, SBI would still have an important role in
the battle against alcohol-related harm.
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